close 74% jaeinvestorite kontodest jääb antud teenusepakkuja juures hinnavahelepingutega kauplemisel kahjumisse. Investeerimisega kaasnevad riskid ja need ei ole sobilikud kõigile investoritele. Hinnavahelepingud on keerukad instrumendid, millega kaasneb võimenduse tõttu suur risk kaotada raha kiiresti. 74% jaeinvestorite kontodest jääb antud teenusepakkuja juures hinnavahelepingutega kauplemisel kahjumisse. Palume teil kaaluda, kas hinnavahelepingute süsteem on teile arusaadav ja kas olete valmis võtma riski, mis suure tõenäoususega on kahjumlik.
Change languageEesti
Ülevaade

MDT

85.26

-0.95%↓

A

120.85

-0.66%↓

VEEV

168.97

+0.64%↑

HQY

86.11

+0.21%↑

NEOG

9.63

+1.37%↑

MDT

85.26

-0.95%↓

A

120.85

-0.66%↓

VEEV

168.97

+0.64%↑

HQY

86.11

+0.21%↑

NEOG

9.63

+1.37%↑

MDT

85.26

-0.95%↓

A

120.85

-0.66%↓

VEEV

168.97

+0.64%↑

HQY

86.11

+0.21%↑

NEOG

9.63

+1.37%↑

MDT

85.26

-0.95%↓

A

120.85

-0.66%↓

VEEV

168.97

+0.64%↑

HQY

86.11

+0.21%↑

NEOG

9.63

+1.37%↑

MDT

85.26

-0.95%↓

A

120.85

-0.66%↓

VEEV

168.97

+0.64%↑

HQY

86.11

+0.21%↑

NEOG

9.63

+1.37%↑

Kodu・Aktsiate loetelu・CorMedix Inc
Search

CorMedix Inc

Suletud

SektorTervishoid

7.6 2.84

Tugev "osta" hinnang

Hinna uuendus 20. apr 2026, 19:59 UTC

OstaMüü

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

7.23

Max

7.7

Põhinäitajad

By Trading Economics

Sissetulek

-95M

14M

Müük

24M

129M

P/E

Sektori keskmine

3.588

63.808

Aktsiakasum

0.16

Kasumimarginaal

10.901

Töötajad

191

EBITDA

9.2M

66M

Soovitused

By TipRanks

Soovitused

Tugev "osta" hinnang

12 kuu keskmine prognoos

+79.3% upside

Dividendid

By Dow Jones

Järgmine tulemuste avaldamine

5. mai 2026

Turustatistika

By TradingEconomics

Turukapital

11M

579M

Eelmine avamishind

4.76

Eelmine sulgemishind

7.6

Tehniline skoor

By Trading Central

Kindlus

Strong Bullish Evidence

9.2 / N/A Toetus ja vastupanu

CorMedix Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

20. apr 2026, 23:49 UTC

Uudisväärsed sündmused

New Zealand 1Q Inflation Higher Than Expected

DJ

Loe

20. apr 2026, 23:10 UTC

Kuumad aktsiad

Stocks to Watch: Amazon, Alaska Air Group, BridgeBio Oncology, AXT

DJ

Loe

20. apr 2026, 22:53 UTC

Suurimad hinnamuutused turgudel

BridgeBio Oncology Shares Rise After FDA Fast-Tracks Pancreatic Cancer Treatment

DJ

Loe

20. apr 2026, 23:45 UTC

Market Talk

Nikkei May Rise on Hopes for U.S.-Iran Peace Talks -- Market Talk

DJ

Loe

20. apr 2026, 23:44 UTC

Market Talk

Gold Consolidates as End of Cease-Fire Looms -- Market Talk

DJ

Loe

20. apr 2026, 23:39 UTC

Market Talk

Rio Tinto Posts Strong Start to Year -- Market Talk

DJ

Loe

20. apr 2026, 23:30 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

DJ

Loe

20. apr 2026, 23:30 UTC

Market Talk

Global Equities Roundup: Market Talk

DJ

Loe

20. apr 2026, 23:30 UTC

Market Talk

Super Retail's Earnings Outlook Less Rosy -- Market Talk

DJ

Loe

20. apr 2026, 23:09 UTC

Market Talk

Viva Energy's Refinery Fire More Benign Than Jefferies Thought -- Market Talk

DJ

Loe

20. apr 2026, 22:31 UTC

Omandamised, ülevõtmised, äriostud

Anthropic, Amazon Tighten Bond in $5 Billion Investment and Computing Deal -- WSJ

DJ

Loe

20. apr 2026, 22:26 UTC

Omandamised, ülevõtmised, äriostud

West African Resources Says Sanbrado, Toega Operations Not Subject to Govt Request for Additional Participation

DJ

Loe

20. apr 2026, 22:25 UTC

Omandamised, ülevõtmised, äriostud

West African Resources Plans to Distribute Cash Proceeds to Shareholders Via Special Dividend

DJ

Loe

20. apr 2026, 22:25 UTC

Omandamised, ülevõtmised, äriostud

West African Resources Aims for Acquisition to Be Completed by End-2026

DJ

Loe

20. apr 2026, 22:25 UTC

Omandamised, ülevõtmised, äriostud

West African Resources Says to Work Cooperatively With Govt to Finalize Deal Terms

DJ

Loe

20. apr 2026, 22:25 UTC

Omandamised, ülevõtmised, äriostud

West African Resources Says Acquisition Would Be for A$175 Million

DJ

Loe

20. apr 2026, 22:24 UTC

Omandamised, ülevõtmised, äriostud

West African Resources Says Burkina Faso Govt Issues Decree to Acquire 25% of Kiaka

DJ

Loe

20. apr 2026, 22:15 UTC

Omandamised, ülevõtmised, äriostud

Anthropic, Amazon Tighten Bond in $5 Billion Investment and Computing Deal -- WSJ

DJ

Loe

20. apr 2026, 22:01 UTC

Omandamised, ülevõtmised, äriostud

Amazon Invests $5B in Anthropic Amid Expanded Collaboration

DJ

Loe

20. apr 2026, 21:38 UTC

Market Talk

Apple's New CEO Will Face Immediate Pressure on AI Strategy -- Market Talk

DJ

Loe

20. apr 2026, 21:33 UTC

Omandamised, ülevõtmised, äriostud

Uber Expands Stake In Lucid for Robo-Taxis. This Is How Tesla's Stock Is Responding. -- Barrons.com

DJ

Loe

20. apr 2026, 21:24 UTC

Market Talk

Apple's CEO Change Timing Will Garner Mixed Reaction, Analyst Says -- Market Talk

DJ

Loe

20. apr 2026, 21:24 UTC

Market Talk

Global Equities Roundup: Market Talk

DJ

Loe

20. apr 2026, 21:13 UTC

Tulu

Alaska Air: Expansion of Card Portfolio Expected to Accelerate Loyalty Platform Beyond Incremental $150M Profit Outlined in Alaska Accelerate Strategy

DJ

Loe

20. apr 2026, 21:10 UTC

Tulu

Alaska Air to Move Toward a Single Issuer for Atmos Rewards Credit Cards

DJ

Loe

20. apr 2026, 21:09 UTC

Tulu

Alaska Air Sees 2Q Capacity Up About 1% Year-Over-Year, Down Nearly a Point From Original Views, on 'Proactive Trimming' of May and June Capacity

DJ

Loe

20. apr 2026, 21:08 UTC

Tulu

Alaska Air 'Continues to Operate From a Position of Strength,' With Healthy Balance Sheet, Strong Liquidity, About $20B in Unencumbered Assets

DJ

Loe

20. apr 2026, 21:07 UTC

Tulu

Alaska Air: Taken Together, Rev, Cost and Fuel Assumptions Result in 2Q Adjusted Loss Per Share Estimate of About $1

DJ

Loe

20. apr 2026, 21:05 UTC

Tulu

Alaska Air: This Assumption Adds About $600M of Expense to 2Q, Equivalent to EPS Headwind of $3.60

DJ

Loe

20. apr 2026, 21:05 UTC

Tulu

Alaska Air Expects 2Q Fuel Cost to Average About $4.50 Based on Forward Curve Today

DJ

Loe

Võrdlus sarnastega

Hinnamuutus

CorMedix Inc Prognoos

Hinnasiht

By TipRanks

79.3% tõus

12 kuu keskmine prognoos

Keskmine 13.25 USD  79.3%

Kõrge 14 USD

Madal 13 USD

Põhineb 5 Wall Streeti analüütiku instrumendi CorMedix Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Tugev "osta" hinnang

5 ratings

5

Osta

0

Hoia

0

Müü

Põhineb 5 analüütiku instrumendi CorMedix Inc aktsia reitingul - viimase 3 kuu andmed.

Tehniline skoor

By Trading Central

9.2 / N/AToetus ja vastupanu

Lühikene perspektiiv

Strong Bullish Evidence

Recent bullish events outweigh bearish events.

Keskpikk perspektiiv

Weak Bullish Evidence

Recent bullish events outweigh bearish events.

Pikk perspektiiv

Strong Bullish Evidence

All events are bullish.

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest CorMedix Inc

CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States. Its lead product candidate is DefenCath, an antimicrobial catheter lock solution to reduce the incidence of catheter-related bloodstream infections in adult patients with kidney failure. The company was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. CorMedix Inc. was incorporated in 2006 and is based in Berkeley Heights, New Jersey.

Muud aktsiad sektorist

MDT

Medtronic PLC

85.26

↓-0.95%

A

Agilent Technologies Inc

120.85

↓-0.66%

VEEV

Veeva Systems Inc

168.97

↑ +0.64%

HQY

HealthEquity Inc

86.11

↑ +0.21%

NEOG

Neogen Corp

9.63

↑ +1.37%
help-icon Live chat